Kythera Biopharmaceuticals Inc (KYTH) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because KYTH is now in overbought territory with an ...
The company has seen two negative revisions and a single positive revision in the past two months. Also, its earnings consensus has moved lower over the same time frame, suggesting there may be ...
Looking back to 7 days ago, Kythera Biopharmaceuticals, Inc. (NASD: KYTH) priced a 2,604,168 share secondary stock offering at $48.00 per share. Buyers in that offering made a considerable investment ...
As of June 28 at 6:07:38 p.m. EDT. Market Open.
Kythera Biopharmaceuticals Inc ( KYTH) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because KYTH is now in overbought territory with an ...
NEW YORK (TheStreet) — Shares of Kythera Biopharmaceuticals (KYTH) were soaring, sharply up 22.05% to $74.11 in early market trading Wednesday, after the company announced it is being acquired by ...
Looking back to 44 days ago, Kythera Biopharmaceuticals, Inc. (Symbol: KYTH) priced a 2,604,168 share secondary stock offering at $48.00 per share. Buyers in that offering made a considerable ...
To the average investor, there are tons of methods market participants can use to track publicly traded companies. Two of the most useful are hedge fund and insider trading activity. At Insider Monkey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results